Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

University of Toronto

$14,775.00

An assessment of market opportunities for pro-healing polymer (PHP) technology

FY 2017-18

Summary
The discovery/invention that is the subject of this NSERC I2I Market assessment proposal is a novel syntheticpolymer referred to as pro-healing polymer (PHP) (Univ.Toronto Disclosure No. 10002755, US provisionalapplication No.62/037,359, PCT No. PCT/CA2015/000461). PHP has the ability to reduce implant device-associatedinflammation by influencing initial adsorbed protein immediately following implantation. A majorcomplication associated with implanted devices is the formation of a fibrotic capsule as a result of a chronicinflammatory response that in many instances can impede the device's performance. This chronic inflammatoryresponse is mediated by white blood cells, particularly monocytes and derived macrophages. Following thesurgical implantation of a biomaterial, whether it is part of a biomedical device or tissue engineered product,the first biological event that occurs is the adsorption of proteins from protein-rich bodily fluids (e.g. blood,interstitial fluid). Blood monocytes and macrophages that adhere to the implants thus interact with thebiomaterial-associated adsorbed protein layer, rather than directly with the device itself. PHP is prepared usingthree monomers which can be selected to (1) provide desirable mechanical properties depending on therequirements of a proposed application, (2) exhibit biodegradable/bioresorbable or substantiallynon-degradable properties, and (3) be manufactured through both heat and light curing methods. A commonfeature of PHP is the ability to modulate the pro-inflammatory serum protein immunoglobulin G (IgG) to limitexposure of pro-inflammatory domains, thus reducing activation of adherent monocytes and macrophages thatcan damage the implant. The main aim of the proposed market assessment is to assess the market potential ofthe proposed product through assessment of market size, competitive landscape, barriers to entry, and markettrends. Analysis will also be performed to assess potential factors affecting the commercialization of thetechnology, including issues regarding product adoption by end-users, product positioning, potential
Program
Idea to Innovation
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
514303-2017
Name nom
Santerre, Paul
Department département
Dentistry, Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
14775
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
An assessment of market opportunities for pro-healing polymer (PHP) technology
Keyword
NSERC
Application summary
The discovery/invention that is the subject of this NSERC I2I Market assessment proposal is a novel syntheticpolymer referred to as pro-healing polymer (PHP) (Univ.Toronto Disclosure No. 10002755, US provisionalapplication No.62/037,359, PCT No. PCT/CA2015/000461). PHP has the ability to reduce implant device-associatedinflammation by influencing initial adsorbed protein immediately following implantation. A majorcomplication associated with implanted devices is the formation of a fibrotic capsule as a result of a chronicinflammatory response that in many instances can impede the device's performance. This chronic inflammatoryresponse is mediated by white blood cells, particularly monocytes and derived macrophages. Following thesurgical implantation of a biomaterial, whether it is part of a biomedical device or tissue engineered product,the first biological event that occurs is the adsorption of proteins from protein-rich bodily fluids (e.g. blood,interstitial fluid). Blood monocytes and macrophages that adhere to the implants thus interact with thebiomaterial-associated adsorbed protein layer, rather than directly with the device itself. PHP is prepared usingthree monomers which can be selected to (1) provide desirable mechanical properties depending on therequirements of a proposed application, (2) exhibit biodegradable/bioresorbable or substantiallynon-degradable properties, and (3) be manufactured through both heat and light curing methods. A commonfeature of PHP is the ability to modulate the pro-inflammatory serum protein immunoglobulin G (IgG) to limitexposure of pro-inflammatory domains, thus reducing activation of adherent monocytes and macrophages thatcan damage the implant. The main aim of the proposed market assessment is to assess the market potential ofthe proposed product through assessment of market size, competitive landscape, barriers to entry, and markettrends. Analysis will also be performed to assess potential factors affecting the commercialization of thetechnology, including issues regarding product adoption by end-users, product positioning, potential